In the recent study, Ramalingam found that people with Stage III lung cancer who had EGFR mutations had an 84% lower risk of ...

The trial’s primary endpoint is pCR, with secondary endpoints including event-free survival (EFS), overall survival, safety, ...

The potential of computational chemistry to revolutionise cancer treatment in Nigeria represents a paradigm shift in medical ...

Viridian Therapeutics received breakthrough therapy designation from the FDA for veligrotug for the treatment of thyroid eye ...

The role of EGFR in KRASG12D-driven tumorigenesis was studied using mouse CRC organoids with KRAS-APC-TP53 mutations and ...

Folic acid plays a dual role in breast cancer depending on dose and context. While moderate intake may reduce risk, high ...

The table below is a review of notable updates that occurred in April 2025 for investigational products in development.

Prior screening mammography is associated with earlier stage at breast cancer diagnosis and lower breast cancer mortality ...